Acute Hyperglycemia Due to Topical Corticosteroid Administration

被引:2
|
作者
Sue, Laura Y. [1 ,2 ]
Milanesi, Anna [3 ,4 ,5 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, VA Greater Los Angeles Healthcare Syst, 900 Vet Ave,24-130 Warren Hall, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Dept Med, 900 Vet Ave,24-130 Warren Hall, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Vet Affairs Greater Los Angeles Healthcare Syst, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol, Dept Med, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA
[5] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA
关键词
DIABETES-MELLITUS;
D O I
10.1155/2019/6058076
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present the case of a 71-year-old man with longstanding, previously well-controlled type 1 diabetes who developed acute hyperglycemia. His insulin requirements, via his insulin pump, increased to nearly five times his typical daily dose. The patient was admitted for evaluation and treatment and started on an insulin infusion. He had minimal insulin requirements with the insulin infusion. History revealed recent use of a super potent topical corticosteroid for a psoriasis flare. The patient was transitioned back to his insulin pump, using his prior to admission settings. He was advised to discontinue using his topical corticosteroid. He had no further hyperglycemic episodes. The clinical presentation is suggestive of corticosteroid-induced hyperglycemia, suggesting that clinically significant changes can occur even with short duration use, particularly with high potency steroids used. This is to our knowledge the first case reported in which the patient required a very significant amount of extra insulin (nearly five times his typical total daily dose) after using high potency topical steroid cream. This case highlights the potentially detrimental effect of topical corticosteroid use in patients with diabetes.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Topical Corticosteroid Addiction and Phobia
    Ghosh, Aparajita
    Sengupta, Sujata
    Coondoo, Arijit
    Jana, Amlan Kusum
    INDIAN JOURNAL OF DERMATOLOGY, 2014, 59 (05) : 465 - 468
  • [42] Hypertrichosis and topical corticosteroid use
    Ando, Yuya
    Ono, Sachiko
    Ono, Yosuke
    Miura, Yoshinori
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2022, 89 (02) : 71 - 72
  • [43] TOPICAL CORTICOSTEROID-THERAPY
    MILLIKAN, LE
    MISSOURI MEDICINE, 1981, 78 (05) : 237 - 242
  • [44] Treatment of topical corticosteroid withdrawal
    Velasco, R. C.
    Simpson, E.
    Grinich, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S133 - S133
  • [45] ONE MORE TOPICAL CORTICOSTEROID
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1978, 20 (25): : 112 - 112
  • [46] Iatrogenic severe hyperglycemia due to parenteral administration of glucose in children - a case series
    Bruns, Nora
    Lordemann, Anja Grosse
    Rasche, Tobias
    Meyburg, Jochen
    Krueger, Marcus
    Wieg, Christian
    Gratopp, Alexander
    Hoppenz, Marc
    Heitmann, Friedhelm
    Hoppen, Thomas
    Loeffler, Guenther
    Felderhoff-Mueser, Ursula
    Dohna-Schwake, Christian
    ITALIAN JOURNAL OF PEDIATRICS, 2020, 46 (01)
  • [47] Selection of an effective topical corticosteroid
    Aung, Tim
    Aung, Sandy Tin
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2021, 50 (09) : 651 - 655
  • [48] CURRENT TOPICAL CORTICOSTEROID PREPARATIONS
    TAN, PL
    BARNETT, GL
    FLOWERS, FP
    ARAUJO, OE
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 14 (01) : 79 - 93
  • [49] Mastocytoma: topical corticosteroid treatment
    Mateo, JR
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2001, 15 (05) : 492 - 494
  • [50] HOW TO CHOOSE A TOPICAL CORTICOSTEROID
    SIGAL, M
    GAZETTE MEDICALE, 1985, 92 (36): : 55 - &